Drug intelligence / Profile preview

Torroks

Development stage: Unknown
Lead developer: Shayana Farm
Modality: Small Molecules
Administration: Intravenous

Overview

**Torroks** is a prescription intravenous solution for parenteral nutrition marketed by Shayana Farm. It is a defined amino-acid and sorbitol infusion containing essential and nonessential L-amino acids, including L-arginine and L-histidine, intended to provide nitrogen substrates for protein synthesis when enteral nutrition is ineffective or not possible. Sorbitol provides an insulin-independent energy source. The product is listed under ATC code B05BA10. ([shayanafarm.com](https://shayanafarm.com/productions/torroks-3/))

Brand names: Torroks
Other names: Торрокс

Beyond the preview

Go deeper on Torroks.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Torroks.

Explore the full profile